General Information of Drug (ID: DMB5TH3)

Drug Name
AA-193 Drug Info
Synonyms
AA-193; 107804-48-8; Furo[2,3-g]-1,2-benzisoxazole-7-carboxylicacid, 5-chloro-7,8-dihydro-3-phenyl-; AC1OCEWV; ACMC-20mb6x; CHEMBL93997; SCHEMBL10512834; CTK0H6407; AKOS030601198; 5-chloro-3-phenyl-7,8-dihydrofuro[2,3-g][1,2]benzoxazole-7-carboxylic acid
Indication
Disease Entry ICD 11 Status REF
Hyperuricaemia 5C55.Y Discontinued in Phase 2 [1]
Cross-matching ID
PubChem CID
6918012
TTD Drug ID
DMB5TH3

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
SAP-001 DM4DP70 Gout FA25 Phase 2 [3]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Glucose transporter type 9 (GLUT9) TTIF3GB GTR9_HUMAN Modulator [2]

References

1 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800003058)
2 Uricosurics inhibit urate transporter in rat renal brush border membrane vesicles. Eur J Pharmacol. 1990 Oct 23;187(3):303-12.
3 Clinical pipeline report, company report or official report of Shanton Pharma Shanghai, China